What's new in IDIS/Web:

 • New Drugs

 • New Diseases

 • FDA Approval Packages

 • Black Box Warnings

 • Advisory Committee Meetings

 • Priority Clinical Practice Guidelines

 • Continuing Education Articles

 

IDIS Training Tools

 

Stay Connected:

 • IDIS on Facebook

 • Join Our Update Lists

 • CAMIPR

 • Monthly Update Information

 

 

 Email: idis@uiowa.edu


Drug Information Resources

IDIS Logo   IDIS Monthly Update Information - February 2011

NEW DRUG TERM
BABASSU
HEMP SEED
HU-1418-IL-2
RETASPIMYCIN

CODE
92510276
92510277
10120955
10120954


NEW DISEASE TERM
HIDRADENITIS
POUCHITIS

CODE
705.83
569.71


FDA APPROVAL PACKAGES

Article Numbers 650572-650585: Eribulin Mesylate, Halaven, FDA Approval Package for NDA 201532. FDA Approval Package 2010.

Article Numbers 650144-650152: Cerivastatin Sodium, Baycol, FDA Approval Package for NDA20-740. FDA Approval Package 1997.

Article Numbers 649677-649692: Tesamorelin Acetate, Egrifta, FDA Approval Package for NDA 022505. FDA Approval Package 2010.

Article Numbers 649601-649615: Ceftaroline Fosamil, Teflaro, FDA Approval Package for NDA 200327. FDA Approval Package 2010.

Article Numbers 649585-649600: Alglucosidase Alfa, Lumizyme, FDA Approval Package for BLA 125291. FDA Approval Package 2010.


BLACK BOX WARNINGS

Article Number 650571: Lurasidone: FDA Black Box Warning. 2010.

Article Number 650570: Gadoxetate Disodium: FDA Black Box Warning. 2010.

Article Number 650569: Gadoversetamide: FDA Black Box Warning. 2010.

Article Number 650568: Gadoteridol: FDA Black Box Warning. 2010.

Article Number 650567: Gadofosveset: FDA Black Box Warning. 2010.

Article Number 650566: Gadodiamide: FDA Black Box Warning. 2010.

Article Number 650565: Gadobenate Dimeglumine: FDA Black Box Warning. 2010.

Article Number 650564: Buprenorphine (Transdermal): FDA Black Box Warning. 2010.


FDA ADVISORY COMMITTEE MEETINGS

Article Numbers 650371-650376: Cardiovascular and Renal Drugs Advisory Committee Meeting, December 8, 2010. FDA Advisory Committee 2010.

Article Numbers 650365-650370: Endocrinologic and Metabolic Drugs Advisory Committee Meeting, December 7, 2010. FDA Advisory Committee 2010.

Article Numbers 650359-650364: Oncologic Drugs Advisory Committee Meeting, December 2, 2010. FDA Advisory Committee 2010.

Article Numbers 650352-650358: Oncologic Drugs Advisory Committee Meeting, December 1, 2010. FDA Advisory Committee 2010.

Article Numbers 650343-650351: Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee, November 30, 2010. FDA Advisory Committee 2010.


PRIORITY CLINICAL PRACTICE GUIDELINES

Article Number 650468: Anonymous. Standards of Medical Care in Diabetes—2011 (Ref Art 650467). Diabetes Care 2011, 34:S11-S61.

Article Number 650153: Anonymous. Full Guideline. Sedation in Children and Young People: Sedation for Diagnostic and Therapeutic Procedures in Children and Young People. NICE Clinical Guideline No. 112 (Ref Art 650153-650156). NICE Clin Guidel 2010.

Article Number 649850: Kris M G, Benowitz S I, Adams S, Diller L, et al. Clinical Cancer Advances 2010: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. J Clin Oncol 2010, 28:5327-5347.

Article Number 649358: Rizzo J D, Brouwers M, Hurley P, Seidenfeld J, et al. American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients with Cancer. J Clin Oncol 2010, 28:4996-5010.

Article Number 649304: Boyce J A, Assa'ad A, Burks A W, Jones S M, et al. Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Am Acad Dermatol 2011, 64:175-192.


CONTINUING EDUCATION ARTICLES

Article Number 650707: Anonymous. Denosumab for Bone Metastases (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 650705-650707]. Med Lett Drugs Ther 2011, 53:8.

Article Number 650706: Anonymous. Botulinum Toxin for Chronic Migraine (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 650705-650707]. Med Lett Drugs Ther 2011, 53:7.

Article Number 650705: Anonymous. Ceftaroline Fosamil (Teflaro) - A New IV Cephalosporin (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 650705-650707]. Med Lett Drugs Ther 2011, 53:5-6.

Article Number 650615: Anonymous. In Brief: Glycopyrrolate Oral Solution for Sialorrhea (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 650613-650615]. Med Lett Drugs Ther 2011, 53:4.

Article Number 650614: Anonymous. Ella: A New Emergency Contraceptive (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 650613-650615]. Med Lett Drugs Ther 2011, 53:3-4.

Article Number 650613: Anonymous. Antiviral Drugs for Influenza (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 650613-650615]. Med Lett Drugs Ther 2011, 53:1-3.

Article Number 650470: Anonymous. Drugs for Parkinson's Disease (0.2 CEU). Treat Guidel Med Lett 2011, 9:1-6.

Article Number 650309: Cada D J, Levien T L, Baker D E. Pegloticase (0.15 CEU). Hosp Pharm 2011, 46:41-47.

Article Number 649629: Timpe E M, Chopra R A. Asenapine: A Novel Atypical Antipsychotic Agent for Schizophrenia and Bipolar I Disorder (0.1 CEU). J Pharm Technology 2010, 26:352-361.

Article Number 649375: Anonymous. Choice of Contraceptives (0.2 CEU). Treat Guidel Med Lett 2010, 8:89-96.


College of Pharmacy